The antiphospholipid syndrome (APS) is a potentially lethal autoimmune clotting disorder that leads to thromboembolic events and obstetric complications and is frequently associated with lupus and other systemic autoimmune diseases. Treatment for APS is currently limited to life-long anticoagulation in order to prevent future thromboembolic events. The cause of APS is unknown but infectious triggers have been implicated in transient induction of antiphospholipid antibodies. The human gut microbiota exceeds 10-fold the number of the host eukaryotic cells, providing a major source for antigenic variation and persistent immune activation. This commensal variability has never been explored for the possibility of molecular mimicry in chronic autoimmune diseases. We hypothesize that commensals within the benign gut microbiota persistently induce pathogenic autoantibodies in genetically predisposed individuals via this mechanism. We have preliminary data to support a fundamental role of the gut microbiota in a murine model of APS. Importantly, we have identified potentially cross-reactive human commensals based on high sequence homologies with both the key T and B cell autoantigenic epitopes of the major autoantigen in APS (2-glycoprotein I; 2GPI) and cultured a candidate commensal. We plan to test the cross-reactive potential of autoreactive T and B cells from APS patients using synthetic peptides and cultured commensal protein extracts. To this end, we propose a study to collect peripheral blood and stool from anti-2GPI-positive APS and control patients longitudinally at three time points. We will define the autoantigenic epitopes targeted by CD4+ T and B cells from APS patients and design PCR- based strategies for targeted screening of the fecal microbiomes for the candidate commensals that carry homologous amino acid sequences to the autoepitopes targeted in these patients. We will also take the unbiased approach of high-throughput 16S rRNA sequencing of the entire fecal microbiome in order to discover previously unknown candidates that track with 2GPI immunoreactivities. This approach already revealed an additional candidate with cross-reactive potential. We propose that fluctuations of autoantigen- mimicking commensals will correlate with titers of anti- 2GPI antibodies in stool or blood and with autoantigen- specific T cells in APS patients. Finally, we have cloned 2GPI-specific CD4 memory T cells and will test + cross-reactivity with cultured key candidates and synthetic peptides. For candidates with both T and B cell epitope homologies, we will also test cross-reactivity of autoantibodies using ELISA and western blot. In summary, we aim to discover the persistent triggers of pathogenic autoantibody production in APS. These studies will represent a novel paradigm for how human autoimmunity can arise and will serve as the basis for development of entirely novel therapeutic avenues in systemic autoimmunity that are aimed at the gut microbiota.

Public Health Relevance

We hypothesize that the potentially deadly autoimmune clotting disease called antiphospholipid syndrome arises because the immune system of patients recognize gut bacteria that contain similar areas as the self protein that is targeted in this syndrome. If true, this discovery would have far-reaching implications for public health since an entirely new set of treatments could be developed for antiphospholipid syndrome. This concept might also be applicable to other autoimmune diseases that afflict a large proportion of the U.S. population.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI118855-04
Application #
9485885
Study Section
Arthritis, Connective Tissue and Skin Study Section (ACTS)
Program Officer
Rothermel, Annette L
Project Start
2015-06-15
Project End
2020-05-31
Budget Start
2018-06-01
Budget End
2019-05-31
Support Year
4
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Yale University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
Manfredo Vieira, S; Hiltensperger, M; Kumar, V et al. (2018) Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science 359:1156-1161
Greiling, Teri M; Dehner, Carina; Chen, Xinguo et al. (2018) Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus. Sci Transl Med 10: